Everolimus for the Prevention of Microvasculopathy in Biopsy in Cardiac Transplant Recipients: Preliminary Results from Re-Evaluation of the RAD B253 Trial

Hiemann, N. E.; Bara, C.; Segovia, J.; Simonsen, S.; Crespo-Leiro, M.; Eiskjaer, H.; Vanhaecke, Johan; Poncelet, Alain; Przybylowski, P.; Frigerio, M.; Lehmkuhl, H. B.; Meyer, R.

doi:10.1016/j.healun.2009.11.507

Everolimus for the Prevention of Microvasculopathy in Biopsy in Cardiac Transplant Recipients: Preliminary Results from Re-Evaluation of the RAD B253 Trial

Hiemann, N. E.

;

Bara, C.

;

Segovia, J.

;

Simonsen, S.

;

Meyer, R.

;et.al.

(2010) 30th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation — Location: Chicago(Il) (21.April.2010)

Files

pdfdocument.pdf

Restricted Access
Adobe PDF
61.79 KB

Request a copy

Details

Authors

Hiemann, N. E.
Author
Bara, C.
Author
Segovia, J.
Author
Simonsen, S.
Author
Poncelet, AlainUCLouvain
Author
Meyer, R.
Author

Affiliations

Citations

APA
Chicago
FWB

Hiemann, N. E., Bara, C., Segovia, J., Simonsen, S., Crespo-Leiro, M., Eiskjaer, H., Vanhaecke, J., Poncelet, A., Przybylowski, P., Frigerio, M., Lehmkuhl, H. B., & Meyer, R. (2010). Everolimus for the Prevention of Microvasculopathy in Biopsy in Cardiac Transplant Recipients: Preliminary Results from Re-Evaluation of the RAD B253 Trial. The Journal of Heart and Lung Transplantation, 29(Suppl. 1), S161. https://doi.org/10.1016/j.healun.2009.11.507 (Original work published 2010)